| A Plus Hospice & Palliative Care 29200 Vassar Street, Livonia, MI, 48152 | |
| (248) 458-0065 |
News Archive
Americans spend billions of dollars each year on antidepressants, but the National Institutes of Health estimates that those medications work for only 60 percent to 70 percent of people who take them.
A startup based on an Indiana University innovation could help federal and international organizations conduct more-efficient quantitative risk assessments of chemicals in food, pharmaceuticals, pesticides and other products.
InSight Health Services Holdings Corp. ("InSight") (OTCBB: ISGT) today announced its financial results for the fourth quarter and fiscal year ended June 30, 2009.
Affymax, Inc. and Takeda Global Research & Development Center, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, today announced preliminary top-line results from the Phase 3 clinical program for the investigational drug, Hematide™/peginesatide, for the treatment of anemia in chronic renal failure patients.
The Industry Council Chairman for the American Telemedicine Association is predicting that 2012 will be lauded as the most significant year ever for telemedicine growth.
› Verified 9 days ago
| Name | A Plus Hospice & Palliative Care |
|---|---|
| Location | 29200 Vassar Street, Livonia, Michigan |
| Hospice ID | 231632 |
| Category | Freestanding Hospice |
| Ownership Type | Proprietary - Individual |
| Profit Type | FOR PROFIT |
| Accreditation Provider | Community Health Accreditation Partner (CHAP) |
| SSA county code | 810 |
News Archive
Americans spend billions of dollars each year on antidepressants, but the National Institutes of Health estimates that those medications work for only 60 percent to 70 percent of people who take them.
A startup based on an Indiana University innovation could help federal and international organizations conduct more-efficient quantitative risk assessments of chemicals in food, pharmaceuticals, pesticides and other products.
InSight Health Services Holdings Corp. ("InSight") (OTCBB: ISGT) today announced its financial results for the fourth quarter and fiscal year ended June 30, 2009.
Affymax, Inc. and Takeda Global Research & Development Center, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, today announced preliminary top-line results from the Phase 3 clinical program for the investigational drug, Hematide™/peginesatide, for the treatment of anemia in chronic renal failure patients.
The Industry Council Chairman for the American Telemedicine Association is predicting that 2012 will be lauded as the most significant year ever for telemedicine growth.
› Verified 9 days ago
| NPI Number | 1659648095 |
| Organization Name | A Plus Hospice & Palliative Care Inc |
| Address | 29200 Vassar St Livonia, Michigan, 48152 |
| Phone Number | (248)485-0065 |
News Archive
Americans spend billions of dollars each year on antidepressants, but the National Institutes of Health estimates that those medications work for only 60 percent to 70 percent of people who take them.
A startup based on an Indiana University innovation could help federal and international organizations conduct more-efficient quantitative risk assessments of chemicals in food, pharmaceuticals, pesticides and other products.
InSight Health Services Holdings Corp. ("InSight") (OTCBB: ISGT) today announced its financial results for the fourth quarter and fiscal year ended June 30, 2009.
Affymax, Inc. and Takeda Global Research & Development Center, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, today announced preliminary top-line results from the Phase 3 clinical program for the investigational drug, Hematide™/peginesatide, for the treatment of anemia in chronic renal failure patients.
The Industry Council Chairman for the American Telemedicine Association is predicting that 2012 will be lauded as the most significant year ever for telemedicine growth.
› Verified 9 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | Not Available | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | Not Available | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | Not Available | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | Not Available | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | Not Available | 97.3 |
| Patients who got timely treatment for shortness of breath | Not Available | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | Not Available | 93.3 |
News Archive
Americans spend billions of dollars each year on antidepressants, but the National Institutes of Health estimates that those medications work for only 60 percent to 70 percent of people who take them.
A startup based on an Indiana University innovation could help federal and international organizations conduct more-efficient quantitative risk assessments of chemicals in food, pharmaceuticals, pesticides and other products.
InSight Health Services Holdings Corp. ("InSight") (OTCBB: ISGT) today announced its financial results for the fourth quarter and fiscal year ended June 30, 2009.
Affymax, Inc. and Takeda Global Research & Development Center, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, today announced preliminary top-line results from the Phase 3 clinical program for the investigational drug, Hematide™/peginesatide, for the treatment of anemia in chronic renal failure patients.
The Industry Council Chairman for the American Telemedicine Association is predicting that 2012 will be lauded as the most significant year ever for telemedicine growth.
› Verified 9 days ago
| Home Health Aides | 3 |
| Counselors | 3 |
| Medical Social Workers | 2 |
| Physicians | 2 |
| Registered Nurses | 2 |
| Other Personnel | 2 |
| Total Employees | 14 |
|---|
News Archive
Americans spend billions of dollars each year on antidepressants, but the National Institutes of Health estimates that those medications work for only 60 percent to 70 percent of people who take them.
A startup based on an Indiana University innovation could help federal and international organizations conduct more-efficient quantitative risk assessments of chemicals in food, pharmaceuticals, pesticides and other products.
InSight Health Services Holdings Corp. ("InSight") (OTCBB: ISGT) today announced its financial results for the fourth quarter and fiscal year ended June 30, 2009.
Affymax, Inc. and Takeda Global Research & Development Center, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, today announced preliminary top-line results from the Phase 3 clinical program for the investigational drug, Hematide™/peginesatide, for the treatment of anemia in chronic renal failure patients.
The Industry Council Chairman for the American Telemedicine Association is predicting that 2012 will be lauded as the most significant year ever for telemedicine growth.
› Verified 9 days ago
| Others | 2 |
| Total Volunteers | 2 |
|---|
News Archive
Americans spend billions of dollars each year on antidepressants, but the National Institutes of Health estimates that those medications work for only 60 percent to 70 percent of people who take them.
A startup based on an Indiana University innovation could help federal and international organizations conduct more-efficient quantitative risk assessments of chemicals in food, pharmaceuticals, pesticides and other products.
InSight Health Services Holdings Corp. ("InSight") (OTCBB: ISGT) today announced its financial results for the fourth quarter and fiscal year ended June 30, 2009.
Affymax, Inc. and Takeda Global Research & Development Center, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, today announced preliminary top-line results from the Phase 3 clinical program for the investigational drug, Hematide™/peginesatide, for the treatment of anemia in chronic renal failure patients.
The Industry Council Chairman for the American Telemedicine Association is predicting that 2012 will be lauded as the most significant year ever for telemedicine growth.
› Verified 9 days ago
| Angela Hospice Home Care Location: 14100 Newburgh Road, Livonia, Michigan, 48154 Phone: (248) 458-0065 |
| A Plus Hospice & Palliative Care Location: 29200 Vassar Street, Livonia, Michigan, 48152 Phone: (248) 458-0065 |
| The Medical Team Hospice Location: 17197 N Laurel Park Drive, Suite 555, Livonia, Michigan, 48152 Phone: (248) 458-0065 |